Skip to main content Skip to left-side content

Submit an Event

You must have an active OUHSC user account to submit events.

Title and navigation
<<<Jun 2018>>>
Jun 2018

Grand Rounds and Seminars

Medical Grand Rounds
1/30/2013 12:15 PM - 1:15 PM
Basic Sciences Education Building, E. Lecture Hall


The Charm of Targeted Therapy:  An Introduction to Personalized Medicine in Oncology

Mohamad Cherry, MD, Assistant Professor, Department of Medicine/Hematology-Oncology (1.0 AMA PRA Category 1 Credit™). This activity has no commercial support.

Upon completion of this activity, participants will be able to: Recognize the changing paradigm in the treatment of malignancies in the last decade.  To identify the major classes of targeted therapies; monoclonal antibodies, tyrosine kinas inhibitors, proteosome inhibitors, etc.   To formulate the major advances and success stories in the management of malignancies over the last few years

Disclosure Report:  Course Director:  Dr. Michael Bronze has no financial relationships or affiliations to disclose.  Planning Committee Members:  Dr. Ben Cowley has been a consultant for Otsuka.  Dr. Douglas Drevets has received grants/research support from NIH.  He has received honorarium from NIH and NIAID.  Dr.  Courtney Houchen has received other financial or material support in that he is the Founder of COARE Biotechnology.  Dr. Tim Lyons has received grants/research support from Merck Sharp & Dohme, Andromeda Biotech, Novo Nordisk, Boehringer-Ingelheim, Corcept Therapeutics, and Registry.  Dr. Dwight Reynolds has received grants/research support from Medtronic.  He has been a consultant for Medtronic and Sorin.  He has received honorarium from Medtronic and Sorin.  Dr. Ira Targoff has been a consultant for the OMRF Clinical Immunology Lab and has received honorarium from Up-to-Date.  Drs. Jackson, Kinasewitz, Selby and Zou have no financial relationships or affiliations to disclose.  Course Contact:  Ms. Kathy Miller has no financial relationships or affiliations to disclose.  Speaker:  Dr. Cherry receives grants/research support from Astellas Pharma Technologies.

Disclaimer Statement:  Statements, opinions and results of studies contained in the program are those of the presenters/authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.  Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted.  However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

For further information contact:
Brenda Wilkerson
271-6651 x6 (54374)

Number of CE Credits: 1